Skip to main content
Year archive

Glenmark Pharmaceuticals ltd — 2026 filings

All 36 regulatory filings released by Glenmark Pharmaceuticals ltd (GLENMARK) in 2026, sourced directly from the official regulator.

36 Filings
2026 Period
2026 filings (36)
Filing Released Lang
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-05-23 English
Enclosed please find herewith the details of Earnings Call slated for Monday, June 01, 2026 at 08:30 a.m. - 09:30 a.m. (IST) for your information and record.
Regulatory Filings
2026-05-23 English
Settlement Agreement: Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015
Legal Proceedings Report
2026-05-23 English
General Updates
Legal Proceedings Report
2026-05-23 English
Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors
Regulatory Filings
2026-05-20 English
Press Release
Regulatory Filings
2026-05-20 English
The trading window has been closed from March 31, 2026 to May 31, 2026 (both days inclusive) for the approval of Audited Financial Results for the quarter and year ended March 31, 2026
Regulatory Filings
2026-05-19 English
Trading Window
Regulatory Filings
2026-05-19 English
Glenmark Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Standalone and ....
Regulatory Filings
2026-05-19 English
Glenmark Pharmaceuticals Inc., USA Launches Vancomycin Hydrochloride for Injection USP, 500 mg/vial and 1 g/vial
Regulatory Filings
2026-05-18 English
Press Release
Regulatory Filings
2026-05-18 English
Press Release
Regulatory Filings
2026-04-09 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2026-04-07 English
General Updates
Regulatory Filings
2026-04-01 English
Press Release
Capital/Financing Update
2026-04-01 English
Press Release
Regulatory Filings
2026-03-20 English
Press Release
Regulatory Filings
2026-03-20 English
Press Release
Capital/Financing Update
2026-03-19 English
Press Release
Regulatory Filings
2026-03-19 English
Press Release
Regulatory Filings
2026-03-16 English
Press Release
Regulatory Filings
2026-03-04 English
Press Release
Capital/Financing Update
2026-02-27 English
General Updates
Regulatory Filings
2026-02-20 English
Copy of Newspaper Publication
Regulatory Filings
2026-02-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-02-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Capital/Financing Update
2026-02-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-02-02 English
General Updates
Regulatory Filings
2026-01-31 English
Investor Presentation
Investor Presentation
2026-01-30 English
Press Release
Interim / Quarterly Report
2026-01-30 English
Outcome of Board Meeting
Regulatory Filings
2026-01-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2026-01-22 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-19 English
Trading Window
Regulatory Filings
2026-01-19 English
Board Meeting — Financial Results
Regulatory Filings
2026-01-19 English
General Updates
Regulatory Filings
2026-01-05 English